GlassScriptPhysician profile
Eric Nordsieck
NPI 1538494042
$6,263.51
in general payments reported to CMS, 2019-2025
27 companies · $2,511 in 2025
The $2,511 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,349 · 2020: $282 · 2021: $504 · 2022: $349 · 2023: $948 · 2024: $320 · 2025: $2,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,729 · Travel and Lodging: $935 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,729.00 |
| Travel and Lodging | $935.49 |
| Education | $115.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,734.19 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Biosense Webster, INC. | $383.58 | 2025 | Carto 3 |
| Biotronik INC. | $374.06 | 2019-2024 | Acticor 7 Vr-T Dx, Amvia Edge |
| Medtronic, INC. | $330.49 | 2021-2025 | Affera Mapping System, Attain Command + Surevalve, Linq II |
| Boston Scientific Corporation | $297.34 | 2019-2025 | Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $193.99 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $154.96 | 2021-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $117.12 | 2019-2024 | |
| Cordis US Corp. | $112.69 | 2025 | Mynx Control Venous |
| Inari Medical, INC. | $96.52 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $74.80 | 2021-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Amarin Pharma, INC. | $53.69 | 2020 | |
| Irhythm Technologies, INC. | $43.24 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $36.81 | 2025 | Camzyos |
| Regeneron Healthcare Solutions, INC. | $30.06 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $26.27 | 2019-2021 | |
| Medtronic Vascular, INC. | $26.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.79 | 2019 | |
| Edwards Lifesciences Corporation | $23.43 | 2025 | Sapien 3 Ultra Resilia |
| Scpharmaceuticals INC. | $21.79 | 2025 | |
| Celgene Corporation | $18.53 | 2023 | Eliquis |
| Lundbeck LLC | $16.41 | 2019 | |
| Amgen INC. | $16.32 | 2019 | |
| Solventum Corporation | $16.17 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.02 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Nordsieck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.